Staffan Wahlin
Overview
Explore the profile of Staffan Wahlin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
741
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wahlin S, Widman L, Hagstrom H
J Intern Med
. 2025 Jan;
297(3):300-311.
PMID: 39777754
Objective: To estimate the incidence, prevalence, and outcomes of patients with diagnosed alpha-1-antitrypsin deficiency (AATD) in Sweden, 2002-2020. Study Design And Setting: The Swedish National Patient Registry was utilized to...
2.
Yuksekyayla O, Batibay E, Wahlin S, Efe C
Turk J Gastroenterol
. 2024 Dec;
36(1):67-68.
PMID: 39635982
No abstract available.
3.
Efe C, Lytvyak E, Eskazan T, Liberal R, Androutsakos T, Gokce D, et al.
Hepatology
. 2024 Sep;
PMID: 39250458
Background And Aims: A limited number of drugs are used as standard or alternative therapies in autoimmune hepatitis (AIH). No specific recommendations are available for patients failing to respond to...
4.
Yuksekyayla O, Kina N, Ulaba A, Ergun M, Batibay E, Simsek C, et al.
Eur J Gastroenterol Hepatol
. 2024 Mar;
36(5):652-656.
PMID: 38477840
Background And Aims: Soluble liver antigen/liver pancreas antibodies (anti-SLA/LP) are specific markers for autoimmune hepatitis (AIH) that have been associated with a distinct clinical phenotype and a more aggressive form...
5.
Simsek C, Wahlin S, Efe C
J Hepatol
. 2024 Mar;
81(1):e41-e42.
PMID: 38458322
No abstract available.
6.
Lissing M, Wang B, Wahlin S
Liver Int
. 2024 Mar;
45(3):e15894.
PMID: 38456621
The porphyrias are a heterogeneous group of metabolic disorders that result from defects in heme synthesis. The metabolic defects are present in all cells, but symptoms are mainly cutaneous or...
7.
Storjord E, Wahlin S, Karlsen B, Hardersen R, Dickey A, Ludviksen J, et al.
Life (Basel)
. 2024 Jan;
14(1).
PMID: 38276268
Acute intermittent porphyria (AIP) is an inherited metabolic disorder associated with complications including kidney failure and hepatocellular carcinoma, probably caused by elevations in the porphyrin precursors porphobilinogen (PBG) and delta-aminolevulinic...
8.
Lissing M, Wester A, Vassiliou D, Floderus Y, Harper P, Sardh E, et al.
J Inherit Metab Dis
. 2023 Aug;
46(6):1186-1194.
PMID: 37650859
Acute intermittent porphyria (AIP) is a rare hereditary metabolic disease characterized by acute attacks and accumulation of the porphyrin precursors 5-aminolevulinic acid (ALA) and porphobilinogen (PBG). Patients with AIP have...
9.
Amouzandeh M, Sundstrom A, Wahlin S, Wernerman J, Rooyackers O, Norberg A
Am J Physiol Gastrointest Liver Physiol
. 2023 Aug;
325(5):G391-G397.
PMID: 37605837
Synthesis of plasma proteins is an important function of the liver that has sparsely been investigated by modern techniques in patients with advanced chronic liver disease (CLD). Twenty-eight well-characterized patients...
10.
Mantel A, Vassiliou D, Lissing M, Stephansson O, Wahlin S, Sardh E
J Inherit Metab Dis
. 2023 Apr;
46(4):675-686.
PMID: 37078226
Current knowledge of pregnancy and perinatal outcomes in women with acute hepatic porphyria (AHP) is largely based on biochemical disease models, case reports, and case series. We performed a nationwide,...